Medtronic Debt Securities, Available-for-Sale, Amortized Cost, Maturity, Allocated and Single Maturity Date, after Year 10 remained flat by 0.0% to $1.43B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 17.8%, from $1.22B to $1.43B.
High levels of long-dated securities indicate a strategy focused on long-term liability matching or yield maximization.
This represents the amortized cost of debt securities in the available-for-sale portfolio that have maturity dates beyon...
Standard maturity bucket reporting for insurance investment portfolios.
other_available_for_sale_securities_debt_maturities_afte_afe479| Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|
| Value | $1.11B | $1.15B | $1.22B | $1.34B | $1.43B | $1.43B |
| QoQ Change | — | +3.5% | +5.8% | +10.0% | +7.0% | +0.0% |
| YoY Change | — | — | — | +20.6% | +24.7% | +17.8% |